Scientist I, Radiochemistry (Isotope Production) at Bristol-Myers Squibb

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, RadiopharmaceuticalsIndustries

Requirements

BS/MS with 5+ years of experience in Radiochemistry or other scientific equivalent work experience
PhD with 3+ years of experience in Radiochemistry or other scientific equivalent work experience
5+ years of experience working with radioactive materials
Experience with wet radiochemistry and/or ion-exchange column separations
Experience with negative pressure gloveboxes and/or hot cells
Experience with analytical methods (HPGe gamma spectroscopy, liquid scintillation, alpha spectroscopy, ICP-MS, ICP-OES, etc.)
Experience in electrochemistry and/or materials science
Experience working with radioactive materials, specifically alpha emitters, is highly desirable
Excellent scientific data analysis and technical writing skills
Excellent professional ethics, integrity, and ability to maintain confidential information

Responsibilities

Provide technical expertise and leadership on radiochemical and analytical methodologies in support of isotope development programs
Analyze and interpret experimental data to drive experimental planning for various aspects of the isotope programs
Support the technical transfer of radiochemical methods from other RayzeBio and third-party sites to the Indianapolis facility
Execute and lead development activities in the Radiochemistry laboratory for various RayzeBio programs
Manage third party vendors in support of analytical and laboratory equipment
Draft GMP documentation including but not limited to SOP’s, forms, and reports
Support activities related to hot cells, gloveboxes, and production cleanrooms
Ensure compliance with NRC, EH&S and US/EU GMP regulatory guidelines as required
Less than 5% of travel required

Skills

Radiochemistry

Ion Exchange Chromatography

Radiometal Synthesis

Process Development

Analytical Testing

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free